Skip to main content

Bloomberg News and Videos — Page 355

Bloomberg Headlines

Bloomberg
Financial

Reddit Climbs, Applied Materials, Gemini Fall | Stock Movers

On this episode of Stock Movers: Drone companies including AeroVironment Inc. (AVAV), Aevex Corp. (AVEX), and Unusual Machines Inc. (UMAC) rose on news that the Trump administration plans to apply a 100% tariff on imports of unmanned aircraft systems and their components. Applied Matierals (AMAT) fell despite an earnings forecast that topped estimates. Investors had a muted reaction to earnings even though the stock has more than doubled this year. Gemini Space Station (GEMI) fell as the crypto platform's earnings report faced crypto market headwinds and a wider-than-expected adjusted Ebitda loss. Reddit (RDDT) climbed on the news that the stock is set to be included in the S&P 500 index.

Read more: Reddit Climbs, Applied Materials, Gemini Fall | Stock Movers
Bloomberg
Financial

US Targets Iran with New Sanctions and 'Economic Fury'

The US has promised a new round of economic sanctions in order to bring Iran back to the negotiating table after months of war. But the Islamic republic has faced many waves of sanctions for decades and it's unclear what effect a new period of "economic fury" will have, as Bloomberg's Tyler Kendall reports.

Read more: US Targets Iran with New Sanctions and 'Economic Fury'
Bloomberg
Financial

Humanoids Market Worth $200BN By 2035: Barclays' Todorova

The market for AI-powered robots and autonomous machines has the potential to balloon into a trillion-dollar opportunity by 2035 in the 'decade of the robot', according to Barclays analyst Zornitsa Todorova. AI-enabled robotics mark a frontier moment in the technology and present a new set of investment opportunities in a world of labor shortages and changing worker preferences. She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe.

Read more: Humanoids Market Worth $200BN By 2035: Barclays' Todorova
Bloomberg
Financial

Robeauté Bets on Rice-Sized Microrobots for Brain Disease

The CEO of French neurotechnology startup Robeauté says its microrobot could unlock precise delivery of drugs and other therapies directly into the brain, The microrobots, which are each the size of grain of rice, are able to reach areas that are difficult to access with existing treatments. Joana Cartocci says the company is targeting first-in-human studies in 2027 and a market launch in the early 2030s. She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe.

Read more: Robeauté Bets on Rice-Sized Microrobots for Brain Disease

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift